KA/EN
Register
Medicines reference
Search
Search
Product

Immunoxantin

Favourites

· Veterinarstvo d.o.o. / VetaPro

1 form: capsule. Not applicable (not a medicine).

Forms and dosesNot applicable (not a medicine)

The dose from the product's label, by species and weight. Check the label of the pack you use.

Choose species and weight; the matching row will be highlighted.
Form Species Weight Dose Frequency Georgia
Capsule · Cat up to 10 kg Cat up to 10 kg 1 capsule
Give one complete capsule whole or open all contents into food. No exact manufacturer dose is published above 10 kg; do not extrapolate. The current web page omits quantities, while a 2025 catalogue permits only version-dependent arithmetic, not batch-assayed exposure.
 · one complete capsule once daily; only established up to 10 kg		 one complete capsule once daily; only established up to 10 kg Georgia Not a medicine
Not applicable (not a medicine)
In the register: Immunoxantin 50 capsules
Verified on: 23 Oct 2026
Capsule · Dog up to 10 kg Dog up to 10 kg 1 capsule
Give one complete capsule whole or open all contents into food. No exact manufacturer dose is published above 10 kg; do not extrapolate. The current web page omits quantities, while a 2025 catalogue permits only version-dependent arithmetic, not batch-assayed exposure.
 · one complete capsule once daily; only established up to 10 kg		 one complete capsule once daily; only established up to 10 kg Georgia Not a medicine
Not applicable (not a medicine)
In the register: Immunoxantin 50 capsules
Verified on: 23 Oct 2026
Details: pack, label wording, sources, registration

Immunoxantin, Capsule

capsule, complementary feed
vetman assessment
vetman’s 10-point assessment brings together a product’s regulatory credibility, clinical efficacy, safety and practicality. Cost-effectiveness is assessed only when reliable data are available. It is informational and does not replace a veterinarian’s clinical judgment for an individual patient.
Dog Nonspecific nutritional immune-support adjunct in dogs or cats up to 10 kg, including infection-risk, vaccination/convalescence and oncology-support claims without replacing cause-specific care
4.8/10
Weak evidence support
vetman assessment

Immunoxantin

capsule, complementary feed
Assessed clinical scopeDog · Nonspecific nutritional immune-support adjunct in dogs or cats up to 10 kg, including infection-risk, vaccination/convalescence and oncology-support claims without replacing cause-specific care · By mouth
Care settingVeterinarian-directed optional home adjunct only after defining the clinical purpose and standard prevention/treatment plan.
vetman score 4.8/10 Weak evidence support
Evidence confidence: Low Georgia: Not a medicine · Verified on 23 Oct 2026

A weakly evidenced small-dog immune-support supplement: plausible biomarker activity does not validate broad infection or oncology claims, and the absence of a >10 kg dose materially limits use.

Regulatory and scientific credibility4.5/10

Exact current identity, category, ingredients, manufacturer and ≤10 kg direction are traceable, and a 2025 catalogue gives quantitative version data; however the current page omits amounts, no batch assay or medicine-style dossier exists and broad pathogen/cancer claims exceed the product-level evidence.

Clinical efficacy4.0/10

No exact-product clinical-outcome study exists. Separate yeast beta-glucan, echinacea and astaxanthin studies show selected immune-marker changes, but doses/formulations differ, protective vaccine titres were not consistently improved and no evidence establishes fewer infections, cancer control or survival.

Safety and tolerability5.5/10

Ingredient-level canine exposure is reasonably documented and serious signals are not prominent, but exact-combination repeated-dose safety, current per-capsule verification, immune-mediated/oncology subgroups, reproduction and clinically important interaction data are absent.

Clinical practicality5.5/10

One daily openable capsule is easy for dogs up to 10 kg, but no dose or course duration is published above 10 kg and “as advised” cannot support calculator extrapolation; unclear endpoints make reassessment essential.

Full-course cost-effectiveness-

Price not assessed: no verified current Georgian full-course price or evidence-defined course duration was available.

Important safety and use flags

  • Complementary feed, not a medicine. It is not an antiviral, antibacterial, antifungal, antiparasitic or anticancer treatment and must not delay diagnosis or standard care.
  • No exact-product dog/cat clinical-outcome study was found. Ingredient studies mainly report immune biomarkers, not fewer infections, faster recovery, tumour response, quality of life or survival.
  • Current official directions establish one complete capsule daily only up to 10 kg. No reproducible dose is published above 10 kg; do not extrapolate by body weight or invent multi-capsule bands.
  • A 2025 catalogue reports 24 g/50 capsules and per-gram quantities, implying a nominal 0.48 g fill and about 96 mg beta-glucan, 96 mg echinacea, 48 mg vitamin C, 24 mg zinc oxide and 2.4 mg astaxanthin per capsule. Treat these as version-dependent arithmetic, not a current batch assay.
  • “Immune stimulation” is not automatically beneficial. Review immune-mediated disease, transplantation, immunosuppressive treatment, chemotherapy and oncology goals before use.
  • Do not substitute it for vaccination, source control, culture-guided antimicrobials, antiparasitic treatment, antiviral/supportive care or evidence-based cancer therapy.
  • Contains lactose, bovine gelatin and yeast products. Review food hypersensitivity, strict elimination diets, GI tolerance and cultural/owner constraints.
  • Add zinc, vitamin C, astaxanthin, echinacea and beta-glucan exposure to the complete diet and all supplements; avoid unquantified stacking and monitor vomiting, diarrhoea, appetite and skin/allergic reactions.
  • Evidence for clinically important echinacea interactions is limited, not proof of no interaction. Review polypharmacy, immunosuppressants and chemotherapy and stop/reassess unexpected effects.
  • Exact-combination safety in pregnancy, lactation, juveniles, severe systemic disease and prolonged/repeated courses is not established; define a clinical objective and stop rule rather than continuing indefinitely.
Assessment sources
  1. Immunoxantin current page2026
  2. Immunoxantin catalogue2025
  3. Canine yeast glucan markers2024
  4. Canine glucan vaccine study2023
  5. Canine glucan immunoglobulins2010
  6. Canine echinacea study2015
  7. Dog-cat astaxanthin PK2010
  8. Canine astaxanthin markers2011
  9. Echinacea interaction review2008
Assessed: 23 Oct 2026The overall score uses 25/25/25/15/10 weights. An unassessed price is excluded and the remaining weights are proportionally renormalised.
Cat Nonspecific nutritional immune-support adjunct in dogs or cats up to 10 kg, including infection-risk, vaccination/convalescence and oncology-support claims without replacing cause-specific care
4.9/10
Weak evidence support
vetman assessment

Immunoxantin

capsule, complementary feed
Assessed clinical scopeCat · Nonspecific nutritional immune-support adjunct in dogs or cats up to 10 kg, including infection-risk, vaccination/convalescence and oncology-support claims without replacing cause-specific care · By mouth
Care settingVeterinarian-directed optional home adjunct only after defining the clinical purpose and standard prevention/treatment plan.
vetman score 4.9/10 Weak evidence support
Evidence confidence: Low Georgia: Not a medicine · Verified on 23 Oct 2026

A weakly evidenced feline immune-support supplement: one-capsule use is practical, but ingredient biomarkers do not establish patient benefit and exact-combination safety/outcomes remain unproved.

Regulatory and scientific credibility4.5/10

Exact current identity, category, ingredients, manufacturer and ≤10 kg direction are traceable, and a 2025 catalogue gives quantitative version data; however the current page omits amounts, no batch assay or medicine-style dossier exists and broad pathogen/cancer claims exceed the product-level evidence.

Clinical efficacy3.5/10

No exact-product feline clinical-outcome study exists. Astaxanthin and unrelated beta-glucan combination studies show absorption or selected immune/microbiome markers, but do not establish fewer infections, cancer control, recovery or benefit from this combination.

Safety and tolerability5.0/10

Cats absorb astaxanthin and indirect ingredient studies are reassuring, but exact-combination feline tolerability, current per-capsule verification, immune-mediated/oncology subgroups, reproduction and interaction data are absent.

Clinical practicality8.0/10

One daily openable capsule is simple and the ≤10 kg label covers most cats, but no evidence-defined course duration exists and the clinical objective/stop rule must be set before use.

Full-course cost-effectiveness-

Price not assessed: no verified current Georgian full-course price or evidence-defined course duration was available.

Important safety and use flags

  • Complementary feed, not a medicine. It is not an antiviral, antibacterial, antifungal, antiparasitic or anticancer treatment and must not delay diagnosis or standard care.
  • No exact-product dog/cat clinical-outcome study was found. Ingredient studies mainly report immune biomarkers, not fewer infections, faster recovery, tumour response, quality of life or survival.
  • Current official directions establish one complete capsule daily only up to 10 kg. No reproducible dose is published above 10 kg; do not extrapolate by body weight or invent multi-capsule bands.
  • A 2025 catalogue reports 24 g/50 capsules and per-gram quantities, implying a nominal 0.48 g fill and about 96 mg beta-glucan, 96 mg echinacea, 48 mg vitamin C, 24 mg zinc oxide and 2.4 mg astaxanthin per capsule. Treat these as version-dependent arithmetic, not a current batch assay.
  • “Immune stimulation” is not automatically beneficial. Review immune-mediated disease, transplantation, immunosuppressive treatment, chemotherapy and oncology goals before use.
  • Do not substitute it for vaccination, source control, culture-guided antimicrobials, antiparasitic treatment, antiviral/supportive care or evidence-based cancer therapy.
  • Contains lactose, bovine gelatin and yeast products. Review food hypersensitivity, strict elimination diets, GI tolerance and cultural/owner constraints.
  • Add zinc, vitamin C, astaxanthin, echinacea and beta-glucan exposure to the complete diet and all supplements; avoid unquantified stacking and monitor vomiting, diarrhoea, appetite and skin/allergic reactions.
  • Evidence for clinically important echinacea interactions is limited, not proof of no interaction. Review polypharmacy, immunosuppressants and chemotherapy and stop/reassess unexpected effects.
  • Exact-combination safety in pregnancy, lactation, juveniles, severe systemic disease and prolonged/repeated courses is not established; define a clinical objective and stop rule rather than continuing indefinitely.
Assessment sources
  1. Immunoxantin current page2026
  2. Immunoxantin catalogue2025
  3. Feline astaxanthin markers2011
  4. Feline glucan blend study2026
  5. Feline combination glucan study2025
  6. Dog-cat astaxanthin PK2010
  7. Echinacea interaction review2008
Assessed: 23 Oct 2026The overall score uses 25/25/25/15/10 weights. An unassessed price is excluded and the remaining weights are proportionally renormalised.
Composition / strength
Formulation Type
Capsule
Administration route
By mouth
Manufacturer
Veterinarstvo d.o.o. / VetaPro · Serbia
Registration
Georgia Not a medicine
Not applicable (not a medicine)
In the register: Immunoxantin 50 capsules
Verified on: 23 Oct 2026
 EU Not a medicine
Not applicable (not a medicine)
Verified on: 23 Oct 2026
 UK Not a medicine
Not applicable (not a medicine)
Verified on: 23 Oct 2026
 US Not a medicine
Not applicable (not a medicine)
Verified on: 23 Oct 2026
Controlled in Georgia
Unknown
Information not fully verified Current exact directions establish one complete capsule PO once daily only up to 10 kg body weight; it may be given whole or opened into food. No reproducible manufacturer dose is published above 10 kg, so do not extrapolate or create multi-capsule weight bands. A 2025 catalogue reports a 24 g/50-capsule pack and quantities per gram, but the current official page omits quantities; derived per-capsule values are version-dependent rather than a batch assay.
DoseSpeciesWeightRouteFrequencySource
1 capsule
Give one complete capsule whole or open all contents into food. No exact manufacturer dose is published above 10 kg; do not extrapolate. The current web page omits quantities, while a 2025 catalogue permits only version-dependent arithmetic, not batch-assayed exposure.
 Cat up to 10 kg By mouth one complete capsule once daily; only established up to 10 kg
Immunoxantin current page
Manufacturer material
Information published by the maker or a seller, such as a datasheet or product page. A medicines regulator has not necessarily reviewed it.
Immunoxantin 50 capsules - current exact qualitative composition, directions and claims
VetaPro, 2026
1 capsule
Give one complete capsule whole or open all contents into food. No exact manufacturer dose is published above 10 kg; do not extrapolate. The current web page omits quantities, while a 2025 catalogue permits only version-dependent arithmetic, not batch-assayed exposure.
 Dog up to 10 kg By mouth one complete capsule once daily; only established up to 10 kg
Immunoxantin current page
Manufacturer material
Information published by the maker or a seller, such as a datasheet or product page. A medicines regulator has not necessarily reviewed it.
Immunoxantin 50 capsules - current exact qualitative composition, directions and claims
VetaPro, 2026

Professional reference for veterinary professionals. Not advertising and not a substitute for the product label/SPC.

For veterinary professionals only. It does not replace clinical judgement or the product label; check the dose in the official label (SPC). vetman is not liable for harm caused by using this information.

Trademarks belong to their owners; vetman is not affiliated with the manufacturers and receives no payment from them.

The database is protected under Chapter VII of the Law of Georgia on Copyright and Related Rights; automated or bulk copying is prohibited.

This reference is still growing. Missing a product? Let us know. · Report an error or request an addition · Updated: 23 Oct 2026

All of this shows in vetman as you prescribe

The dose for the patient's weight, registration in Georgia and controlled status, right on the prescription.

Register Demo ↗